UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of Pharmacokinetic and Pharmacodynamic Drug–Drug Interaction of Sacubitril/Valsartan (LCZ696) and Sildenafil in Patients With Mild‐to‐Moderate Hypertension

Clinical pharmacology and therapeutics, 2018-03, Vol.103 (3), p.468-476

2018

Volltextzugriff (PDF)

PK/PD modelling and simulations: utility in drug development

Drug discovery today, 2008-04, Vol.13 (7), p.341-346

Rajman, Iris

2008

Volltextzugriff (PDF)

Comparative efficacy and safety of aliskiren and irbesartan in patients with hypertension and metabolic syndrome

Journal of human hypertension, 2011-03, Vol.25 (3), p.186-195

2011

Volltextzugriff (PDF)

Nano-Tera.ch: Engineering the Future of Systems for Health, Environment and Energy

1st ed. 2019., 2018

Volltextzugriff (PDF)

Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic men

Atherosclerosis, 1996-09, Vol.125 (2), p.231-242

1996

Volltextzugriff (PDF)

Particle size: the key to the atherogenic lipoprotein?

QJM : An International Journal of Medicine, 1994-12, Vol.87 (12), p.709-720

1994

Volltextzugriff (PDF)

Adverse change in low-density lipoprotein subfractions profile with oestrogen-only hormone replacement therapy

QJM : An International Journal of Medicine, 1996-10, Vol.89 (10), p.771-778

1996

Volltextzugriff (PDF)

Low-density lipoprotein subfraction profiles in chronic renal failure

Nephrology, dialysis, transplantation, 1998-09, Vol.13 (9), p.2281-2287

1998

Volltextzugriff (PDF)

LDL particle size : an important drug target?

British journal of clinical pharmacology, 1999-08, Vol.48 (2), p.125-133

1999

Volltextzugriff (PDF)

Sudden cardiac death and the potential role of beta-adrenoceptor-blocking drugs

Postgraduate Medical Journal, 1993-12, Vol.69 (818), p.903-911

1993

Volltextzugriff (PDF)

Cardioprotective therapeutics--drugs used in hypertension, hyperlipidaemia, thromboembolism, arrhythmias, the postmenopausal state and as anti-oxidants

Postgraduate Medical Journal, 1994-05, Vol.70 (823), p.329-343

1994

Volltextzugriff (PDF)

Pergolide: multiple-dose pharmacokinetics in patients with mild to moderate Parkinson disease

Clinical neuropharmacology, 2005-05, Vol.28 (3), p.120-125

2005

Volltextzugriff (PDF)

Inhibitory effects of low-density lipoproteins from men with type II diabetes on endothelium-dependent relaxation

Journal of the American College of Cardiology, 2000-05, Vol.35 (6), p.1622-1627

2000

Volltextzugriff (PDF)

Evaluation of Methods for Improving Precision of Blood Pressure Measurements in Phase I Clinical Trials

Journal of clinical pharmacology, 2004-05, Vol.44 (5), p.457-463

2004

Volltextzugriff (PDF)

The oxidation hypothesis of atherosclerosis

The Lancet (British edition), 1994-11, Vol.344 (8933), p.1363-1364

1994

Volltextzugriff (PDF)

LDL particle size: an important drug target?

British journal of clinical pharmacology, 1999-08, Vol.48 (2), p.125-133

1999

Volltextzugriff (PDF)

Radiochemical study of the sorption of trace elements. V. Adsorption and desorption of bivalent mercury on polyethylene

Collection of Czechoslovak chemical communications, 1969, Vol.34 (5), p.1375-1386

1969

Volltextzugriff (PDF)

Low density lipoprotein subfractions profile: a coronary risk factor modified by renal disease, HRT and lipid lowering therapy

Rajman, I

1996

Volltextzugriff (PDF)

A risk-benefit assessment of celiprolol in the treatment of cardiovascular disease

Drug safety, 1994-01, Vol.10 (3), p.202-232

1994

Volltextzugriff (PDF)

A risk-benefit assessment of celiprolol in the treatment of cardiovascular disease

Drug safety, 1994-03, Vol.10 (3), p.220-232

1994

Volltextzugriff (PDF)

Cardioprotective therapeutics : drugs used in hypertension, hyperlipidaemia, thromboembolism, arrhythmias, the postmenopausal state and as anti-oxidant

Postgraduate medical journal, 1994, Vol.70 (823), p.329-343

1994

Volltextzugriff (PDF)

Enanthema fixum as side effect in the use of a combination of trimethoprim and sulfamethoxazole

Vojnosanitetski pregled, 1992-01, Vol.49 (1), p.30

1992

Volltextzugriff (PDF)

Low Density Lipoprotein Particle Size Profile and Oestrogen-Only Hormone Replacement Therapy Evidence for an Adverse Effect on Atherogenesis?

Clinical Science, 1996-02, Vol.90 (s34), p.10-10P

1996

Volltextzugriff (PDF)

MicroRNAs in neural development: from master regulators to fine-tuners

Development (Cambridge), 2017-07, Vol.144 (13), p.2310-2322

2017

Volltextzugriff (PDF)

Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence

Cell metabolism, 2018-03, Vol.27 (3), p.529-547

2018

Volltextzugriff (PDF)

1 – 25 von 214

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(161)
Mit Volltextzugriff
(166)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(178)
Polnisch
(25)
Tschechisch
(10)
Deutsch
(3)
Spanisch
(1)
Serbian
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(98)
Life Sciences & Biomedicine
(68)
Humans
(48)
Male
(31)
Female
(27)
Middle Aged
(25)
Technology
(22)
Pharmacology & Pharmacy
(20)
Computer Science
(19)
Adult
(18)
Animals
(18)
Biological And Medical Sciences
(12)
Aminobutyrates - Pharmacokinetics
(11)
Drug Combinations
(11)
Medical Sciences
(11)
Tetrazoles - Pharmacokinetics
(11)
Angiotensin Receptor Antagonists - Pharmacokinetics
(10)
Applied Sciences
(10)
Artificial Intelligence
(10)
Cell Biology
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Evaluation of Pharmacokinetic and Pharmacodynamic Drug–Drug Interaction of Sacubitril/Valsartan (LCZ696) and Sildenafil in Patients With Mild‐to‐Moderate Hypertension

PK/PD modelling and simulations: utility in drug development

Comparative efficacy and safety of aliskiren and irbesartan in patients with hypertension and metabolic syndrome

Nano-Tera.ch: Engineering the Future of Systems for Health, Environment and Energy

Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic men

Particle size: the key to the atherogenic lipoprotein?

Adverse change in low-density lipoprotein subfractions profile with oestrogen-only hormone replacement therapy

Low-density lipoprotein subfraction profiles in chronic renal failure

LDL particle size : an important drug target?

Sudden cardiac death and the potential role of beta-adrenoceptor-blocking drugs

Cardioprotective therapeutics--drugs used in hypertension, hyperlipidaemia, thromboembolism, arrhythmias, the postmenopausal state and as anti-oxidants

Pergolide: multiple-dose pharmacokinetics in patients with mild to moderate Parkinson disease

Inhibitory effects of low-density lipoproteins from men with type II diabetes on endothelium-dependent relaxation

Evaluation of Methods for Improving Precision of Blood Pressure Measurements in Phase I Clinical Trials

The oxidation hypothesis of atherosclerosis

LDL particle size: an important drug target?

Radiochemical study of the sorption of trace elements. V. Adsorption and desorption of bivalent mercury on polyethylene

Low density lipoprotein subfractions profile: a coronary risk factor modified by renal disease, HRT and lipid lowering therapy

A risk-benefit assessment of celiprolol in the treatment of cardiovascular disease

A risk-benefit assessment of celiprolol in the treatment of cardiovascular disease

Cardioprotective therapeutics : drugs used in hypertension, hyperlipidaemia, thromboembolism, arrhythmias, the postmenopausal state and as anti-oxidant

Enanthema fixum as side effect in the use of a combination of trimethoprim and sulfamethoxazole

Low Density Lipoprotein Particle Size Profile and Oestrogen-Only Hormone Replacement Therapy Evidence for an Adverse Effect on Atherogenesis?

MicroRNAs in neural development: from master regulators to fine-tuners

Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence

Suchergebnisse filtern